Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.71% Nasdaq Up1.29%

Gilead Sciences Inc. (GILD)

-NasdaqGS

40.54 Feb 5, 4:00PM EST

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2011Dec 30, 2010Dec 30, 2009
Total Revenue 8,385,385   7,949,420   7,011,383  
Cost of Revenue2,124,410  1,869,876  1,595,558  
Gross Profit 6,260,975   6,079,544   5,415,825  
Operating Expenses
Research Development1,229,151  1,072,930  939,918  
Selling General and Administrative1,241,983  1,044,392  946,686  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 3,789,841   3,962,222   3,529,221  
Income from Continuing Operations
Total Other Income/Expenses Net66,581  60,287  42,397  
Earnings Before Interest And Taxes3,856,422  4,022,509  3,571,618  
Interest Expense205,418  108,961  69,662  
Income Before Tax3,651,004  3,913,548  3,501,956  
Income Tax Expense861,945  1,023,799  876,364  
Minority Interest14,578  11,508  10,163  
Net Income From Continuing Ops2,803,637  2,901,257  2,635,755  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 2,803,637   2,901,257   2,635,755  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 2,803,637   2,901,257   2,635,755  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.